Article
A Review of Genomic Testing and SDH ‐ Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
1 Feb 2025
Abstract excerpt
Gastrointestinal Stromal Tumors (GISTs) have seen significant advancements in their diagnosis and management, driven by targeted therapeutic development and molecular testing. The identification of mutations in genes such as KIT and PDGFRA has transformed treatment approaches, particularly through targeted therapies like imatinib, which have improved patient outcomes. This review explores the critical role of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
